Get-listed-729x90
rareLife Solutions
Location: 8 Wright Street, Suite 107, Westport, Connecticut, United States United States
Founded in: 2013
Stage: Post-launch
Number of employees: 1-5
Funding history:
- Date: 11/2016, Seed: $3 M (post valuation: $8000000).
Investors: Dan Donovan, Nick Kiratsous, Maureen Garrity, marshall kiev, Larry Berman
Short URL: vator.co/clear-pharma
Followers (6)
Awards and mentions
26185_3964
The Top Innovative Products of 2015. A look at the Years most groundbreaking companies, divisions, startups, products, services and strategies revolutionizing the healthcare industry
Get-listed-300x250

rareLife Solutions

Collaboration - Science - Technology
Startup/business
Westport, Connecticut, United States United States
http://onevoice.world/
2
  • About
  • >
  • Activities
  • >
  • Documents
  • >
  • News
Company description

Onevoice is a ground-breaking encouragement and knowledge software platform designed to build supercharged rare disease communities. 

Our platform addresses 2 emerging trends in the healthcare sector: patient-centricty and collaboration and is targeted at the fast growing rare disease market. onevoice, adresses 3 major unmet needs: 1) emotional support for those who need it most; 2) knowledge for the rare disease communtiy members who desperately crave any information they can get about their rare disease; and 3) demystifies the world of clinical trials where so many rare patients end up. onevoice is a multi-stakeholder platform encouraging collaboration among all stakeholders - including patients, caregivers, advocates, physicians, healthcare professionals and industry partners such as advocacy groups, professional societies, pharmaceutical and medical device manufacturers and private companies - to improve disease awareness and understanding and accelerate clinical research.

As we build our rare communities, we capture data. We capture the data that is so often lacking in rare diseases: longitudnal patient experience data. We offer our sponsors an opportnity to understand that rare patient journey from the patient and caregiver perspective. We offer a number of options to capture data and learn more about the communitiy, and the disease. And now, the FDA wants that experiential data as part of NDA submissions.

Learn more at www.onevoice.world.






Ps_26185_6077

Ps_26185_6078


Team
  • T Anthony Howell
    T Anthony Howell | Founder
  • Dan Donovan
    Dan Donovan | Founder
    There has to be a better way. That thinking inspired Dan to create onevoice, a software solution providing "guided communities" in rare diseases that encourage collaboration, accelerate disease understanding and advance clinical trial research.
  • Derek Low
    Derek Low | Team member
Business model

We have 3 opportunities for revenue generation from our onevoice software platform: 1) annual sponsorship - typically a pharma co partnering with an advocacy group, 2) services eg community building services and 3) data services. We also are developing a medical communications group to provide scientifically driven communication solutions to companies in the rare disease space which we plan to launch in 2017.

Competitive advantage

First to market with a comprehensive solution to build guided communities in rare disease.

Robust onevoice solution offers more depth and addresses more needs than other "competitors" in our space.

Founding partners who have successfully created and exited previous companies.

Forward looking development plan with robust features not yet intruduced that will increase the value of the platform.

Investors
Dan Donovan
There has to be a better way. That thinking inspired Dan to create onevoice, a software solution providing "guided communities" in rare diseases that encourage collaboration, accelerate disease understanding and advance clinical trial research.
Investor Deafult Image
Jeff Jacob - Unconfirmed
Investor Deafult Image
William Clemens III - Unconfirmed
Investor Deafult Image
Matt Porio - Unconfirmed